Abstract
Purpose The purpose was to analyze the histological aspects of irises and trabeculums by transmission electron microscopy (TEM) in patients who had or had not received latanoprost therapy. Materials and methods Seven patients with pseudoexfoliation glaucoma were enrolled in the study. Four of them had been using latanoprost monotheraphy for 2 months. Iris samples were obtained by peripheral iridectomy. Trabeculum samples were obtained during the trabeculectomy without use of antimetabolites. The specimens were further processed for transmission electron microscopy. Results There was extracellular pigmentation in the iris stroma in four patients treated with latanoprost, whereas in the control group there was no free melanin in the stroma. Intracellular pigment in fibroblasts, melanocytes, or both was present in all samples in the study group. More pigment accumulation was found in the trabecular endothelial cells of the patients who had received latanoprost therapy. Conclusion Latanoprost therapy causes pigment accumulation in the iris and trabeculum of patients in short-term therapy.
References
Vesti E, Kivela T (2000) Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 19:345–368
Morrison JC, Green WR (1988) Light microscopy of the exfoliation syndrome. Acta Ophthalmol (Copenh) 184:15–27
Kuchle M, Schlötzer-Schrehardt U, Naumann GO (1991) Occurrence of pseudoexfoliative material in parabulbar structures in pseudoexfoliation syndrome. Acta Ophthalmol (Copenh) 69:124–130
Ringvold A (1973) On the occurrence of pseudo-exfoliation material in extrabulbar tissue from patients with pseudo-exfoliation syndrome of the eye. Acta Ophthalmol (Copenh) 51:411–418
Schlötzer-Schrehardt U, Koca MR, Naumann GO, Volkholz H (1992) Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder. Arch Ophthalmol 110:1952–1956
Camras CB, Alm A, Watson P, Stjernschantz J (1996) Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after one year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology 103:1916–1924
Yamamoto T, Kitazawa Y (1997) Iris-color change developed after topical isopropyl unoprostone treatment. J Glaucoma 6:430–432
Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK (2001) Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with openangle glaucoma or ocular hypertension. J Glaucoma 10:414–422
Sherwood M, Brandt J (2001) Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 45:S361–S368
Puska P (1996) The amount of lens exfoliation and chamber-angle pigmentation in exfoliation syndrome with or without glaucoma. Acta Ophthalmol Scand 74:202–204
Schlotzer-Schrehardt U, Naumann GO (1995) Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci 36:1750–1764
Gottanka J, Flugel-Koch C, Martus P, Johnson DH, Lutjen-Drecoll E (1997) Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 38:2435–2446
Kuchle M, Amberg A, Martus P, Nguyen NX, Naumann GO (1997) Pseudoexfoliation syndrome and secondary cataract. Br J Ophthalmol 81:862–866
Morrison JC, Green WR (1988) Light microscopy of the exfoliation syndrome. Acta Ophthalmol Suppl 184:5–27
Alm A, Stjernschantz J (1995) Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology 102:1743–1752
Camras CB, Neely DG, Weiss EL (2000) Latanoprost-induced iris color darkening: a case report with long-term follow-up. J Glaucoma 9:95–98
Cantor LB (2001) Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management. Expert Opin Investig Drugs 10:721–731
Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ (2002) Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol 47:162–175
Stjernschantz J, Ocklind A, Wentzel P, Lake S, Hu DN (2000) Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes. Acta Ophthalmol Scand 78:618–622
Drago F, Marino A, La Manna C (1999) Alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro. Exp Eye Res 68:85–90
Pfeiffer N, Grierson I, Goldsmith H, Hochgesand D, Winkgen-Bohres A, Appleton P (2001) Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study. Arch Ophthalmol 119:191–196
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yildirim, N., Sahin, A., Kara, S. et al. Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study. Int Ophthalmol 30, 93–97 (2010). https://doi.org/10.1007/s10792-008-9285-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-008-9285-4